Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes

被引:63
作者
Gual, P
Gonzalez, T
Grémeaux, T
Barrés, R
Le Marchand-Brustel, Y
Tanti, JF
机构
[1] INSERM, U568, F-06107 Nice 02, France
[2] Fac Med, Inst Federatif Rech 50, F-06107 Nice 02, France
关键词
D O I
10.1074/jbc.M212273200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In 3T3-L1 adipocytes, hyperosmotic stress was found to inhibit insulin signaling, leading to an insulin-resistant state. We show here that, despite normal activation of insulin receptor, hyperosmotic stress inhibits both tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) and IRS-1-associated phosphoinositide 3 (PI 3)kinase activity in response to physiological insulin concentrations. Insulin-induced membrane ruffling, which is dependent on PI 3-kinase activation, was also markedly reduced. These inhibitory effects were associated with an increase in IRS-1 Ser(307) phosphorylation. Furthermore, the mammalian target of rapamycin ( mTOR) inhibitor rapamycin prevented the osmotic shock-induced phosphorylation of IRS-1 on Ser(307). The inhibition of mTOR completely reversed the inhibitory effect of hyperosmotic stress on insulin-induced IRS-1 tyrosine phosphorylation and PI 3-kinase activation. In addition, prolonged osmotic stress enhanced the degradation of IRS proteins through a rapamycin-insensitive pathway and a proteasome-independent process. These data support evidence of new mechanisms involved in osmotic stress-induced cellular insulin resistance. Short-term osmotic stress induces the phosphorylation of IRS-1 on Ser(307) by an mTOR-dependent pathway. This, in turn, leads to a decrease in early proximal signaling events induced by physiological insulin concentrations. On the other hand, prolonged osmotic stress alters IRS-1 function by inducing its degradation, which could contribute to the down-regulation of insulin action.
引用
收藏
页码:26550 / 26557
页数:8
相关论文
共 52 条
[1]   Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action [J].
Aguirre, V ;
Werner, ED ;
Giraud, J ;
Lee, YH ;
Shoelson, SE ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1531-1537
[2]   The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].
Aguirre, V ;
Uchida, T ;
Yenush, L ;
Davis, R ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054
[3]   CAP defines a second signalling pathway required for insulin-stimulated glucose transport [J].
Baumann, CA ;
Ribon, V ;
Kanzaki, M ;
Thurmond, DC ;
Mora, S ;
Shigematsu, S ;
Bickel, PE ;
Pessin, JE ;
Saltiel, AR .
NATURE, 2000, 407 (6801) :202-207
[4]   Rapamycin partially prevents insulin resistance induced by chronic insulin treatment [J].
Berg, CE ;
Lavan, BE ;
Rondinone, CM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (03) :1021-1027
[5]   Heterologous pleckstrin homology domains do not couple IRS-1 to the insulin receptor [J].
Burks, DJ ;
Pons, S ;
Towery, H ;
SmithHall, J ;
Myers, MG ;
Yenush, L ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27716-27721
[6]   Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner [J].
Casanovas, O ;
Miró, B ;
Estanyol, JM ;
Itarte, E ;
Agell, N ;
Bachs, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) :35091-35097
[7]  
Chen D, 1999, MOL CELL BIOL, V19, P4684
[8]   Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathways [J].
Chen, D ;
Elmendorf, JS ;
Olson, AL ;
Li, X ;
Earp, S ;
Pessin, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27401-27410
[9]   Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10 [J].
Chiang, SH ;
Baumann, CA ;
Kanzaki, M ;
Thurmond, DC ;
Watson, RT ;
Neudauer, CL ;
Macara, IG ;
Pessin, JE ;
Saltiel, AR .
NATURE, 2001, 410 (6831) :944-948
[10]   Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ) [J].
Cho, H ;
Mu, J ;
Kim, JK ;
Thorvaldsen, JL ;
Chu, QW ;
Crenshaw, EB ;
Kaestner, KH ;
Bartolomei, MS ;
Shulman, GI ;
Birnbaum, MJ .
SCIENCE, 2001, 292 (5522) :1728-1731